News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Woock John
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/19/2023 |
4
| Woock John (EVP, Chief Mktg/Strtgy Officer) has filed a Form 4 on Axonics, Inc.|
Txns:
| Sold 2,793 shares
@ $67.6174, valued at
$188.9k
Sold 378 shares
@ $67.5113, valued at
$25.5k
Sold 15,000 shares
@ $67.2923, valued at
$1M
Sold 12,044 shares
@ $67.3175, valued at
$810.8k
Exercised 12,044 options to buy
@ $25.82, valued at
$311k
Exercised 15,000 options to buy
@ $14.19, valued at
$212.9k
Exercised 378 options to buy
@ $1.42, valued at
$536.8
Exercised 2,793 options to buy
@ $1.32, valued at
$3.7k
|
|
| 09/12/2022 |
4
| Woock John (Chief Marketing Officer) has filed a Form 4 on Axonics, Inc.|
Txns:
| Sold 3,800 shares
@ $75.0063, valued at
$285k
Sold 3,700 shares
@ $75, valued at
$277.5k
Exercised 3,700 options to buy
@ $1.63, valued at
$6k
Exercised 3,800 options to buy
@ $1.42, valued at
$5.4k
|
|
| 08/26/2022 |
4
| Woock John (Chief Marketing Officer) has filed a Form 4 on Axonics, Inc.|
Txns:
| Sold 6,958 shares
@ $72.9181, valued at
$507.4k
Sold 542 shares
@ $73.3369, valued at
$39.7k
|
|
| 08/12/2022 |
4
| Woock John (Chief Marketing Officer) has filed a Form 4 on Axonics, Inc.|
Txns:
| Sold 9,151 shares
@ $69.4623, valued at
$635.6k
Sold 5,849 shares
@ $70.097, valued at
$410k
Exercised 7,500 options to buy
@ $1.63, valued at
$12.2k
|
|
| 11/17/2021 |
4
| Woock John (Chief Marketing Officer) has filed a Form 4 on Axonics, Inc.|
Txns:
| Sold 2,016 shares
@ $60.1235, valued at
$121.2k
Sold 2,984 shares
@ $60.7279, valued at
$181.2k
Exercised 5,000 options to buy
@ $14.19, valued at
$71k
|
|
| 09/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/19/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/02/2021 |
4
| Woock John (Chief Marketing Officer) has filed a Form 4 on Axonics Modulation Technologies, Inc.|
Txns:
| Sold 4,771 shares
@ $50.3972, valued at
$240.4k
Sold 5,229 shares
@ $51.2048, valued at
$267.7k
|
|
| 02/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/27/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/01/2020 |
4
| Woock John (Chief Marketing Officer) has filed a Form 4 on Axonics Modulation Technologies, Inc.|
Txns:
| Sold 2,400 shares
@ $43.7946, valued at
$105.1k
Sold 100 shares
@ $45.49, valued at
$4.5k
Sold 7,500 shares
@ $44.9414, valued at
$337.1k
Exercised 10,000 options to buy
@ $1.42, valued at
$14.2k
|
|
| 09/02/2020 |
4
| Woock John (Chief Marketing Officer) has filed a Form 4 on Axonics Modulation Technologies, Inc.|
Txns:
| Sold 5,000 shares
@ $43.4534, valued at
$217.3k
Sold 5,000 shares
@ $43.4502, valued at
$217.3k
Exercised 5,000 options to buy
@ $1.63, valued at
$8.2k
Exercised 5,000 options to buy
@ $1.32, valued at
$6.6k
|
|
| 02/27/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/03/2020 |
4
| Woock John (Chief Marketing Officer) has filed a Form 4 on Axonics Modulation Technologies, Inc.|
Txns:
| Exercised 2,667 options to buy
@ $0 |
|
| 01/30/2020 |
4
| Woock John (Chief Marketing Officer) has filed a Form 4 on Axonics Modulation Technologies, Inc.|
Txns:
| Sold 15,000 shares
@ $30.0558, valued at
$450.8k
|
|
| 12/16/2019 |
4
| Woock John (Chief Marketing Officer) has filed a Form 4 on Axonics Modulation Technologies, Inc.|
Txns:
| Granted 5,435 options to buy
@ $0
Granted 15,625 options to buy
@ $25.82, valued at
$403.4k
|
|
| 12/04/2019 |
4
| Woock John (Chief Marketing Officer) has filed a Form 4 on Axonics Modulation Technologies, Inc.|
Txns:
| Sold 14,500 shares
@ $23.4331, valued at
$339.8k
Sold 500 shares
@ $24.204, valued at
$12.1k
|
|
| 02/01/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/30/2018 |
3
| Woock John (Chief Marketing Officer) has filed a Form 3 on Axonics Modulation Technologies, Inc. |
|
|